Investor Presentaiton
Eurofins' Mission is to contribute to global
Health, Safety & Environment with the best in bioanalysis
Eurofins provides testing services in
four main areas that have a strong
impact on human health
Environment
Food
Clinical
Pharmaceuticals
Founded in 1987
⚫ IPO on 24 October 1997 at €0.183
* eurofins
• Eurofins' share price has multiplied by 527 times since IPO
(30% CAGR since IPO as of 30 June 2021 at €96.40)
55,000 employees across network of 1,000 independent
companies in over 50 countries operating 900 laboratories
Over 200,000 validated analytical methods
Over 450 million tests performed each year
• COVID-19 testing:
。 Eurofins created global capacity to help over 20 million
patients monthly
。 Eurofins global PCR testing capabilities in excess of
150,000 PCR tests daily
o Eurofins carried out over 25 million PCR tests in its own
laboratories
9View entire presentation